scPharmaceuticals Inc (NASDAQ:SCPH) has a beta value of 0.37 and has seen 1.08 million shares traded in the last trading session. The company, currently valued at $117.16M, closed the last trade at $2.33 per share which meant it lost -$0.3 on the day or -11.41% during that session. The SCPH stock price is -142.49% off its 52-week high price of $5.65 and -7.3% below the 52-week low of $2.50. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.52 million shares traded. The 3-month trading volume is 406.66K shares.
The consensus among analysts is that scPharmaceuticals Inc (SCPH) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.28.
scPharmaceuticals Inc (NASDAQ:SCPH) trade information
Sporting -11.41% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SCPH stock price touched $2.33 or saw a rise of 24.35%. Year-to-date, scPharmaceuticals Inc shares have moved -34.18%, while the 5-day performance has seen it change -22.33%. Over the past 30 days, the shares of scPharmaceuticals Inc (NASDAQ:SCPH) have changed -27.41%. Short interest in the company has seen 5.67 million shares shorted with days to cover at 9.55.
Wall Street analysts have a consensus price target for the stock at $13, which means that the shares’ value could jump 82.08% from current levels. The projected low price target is $13.0 while the price target rests at a high of $13.0. In that case, then, we find that the current price level is -457.94% off the targeted high while a plunge would see the stock gain -457.94% from current levels.
scPharmaceuticals Inc (SCPH) estimates and forecasts
The company’s shares have lost -49.46% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 109.80%.
5 analysts offering their estimates for the company have set an average revenue estimate of 11.63M for the current quarter. 5 have an estimated revenue figure of 16.43M for the next ending quarter. Year-ago sales stood 6.1M and 8.05M respectively for this quarter and the next, and analysts expect sales will grow by 90.57% for the current quarter and 109.80% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -1.52% over the past 5 years.
SCPH Dividends
scPharmaceuticals Inc is expected to release its next earnings report on 2025-Mar-18 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
scPharmaceuticals Inc (NASDAQ:SCPH)’s Major holders
Insiders own 11.16% of the company shares, while shares held by institutions stand at 84.89% with a share float percentage of 95.56%. Investors are also buoyed by the number of investors in a company, with scPharmaceuticals Inc having a total of 114.0 institutions that hold shares in the company. The top two institutional holders are ORBIMED ADVISORS LLC with over 5.56 million shares worth more than $24.18 million. As of 2024-06-30, ORBIMED ADVISORS LLC held 14.2608% of shares outstanding.
The other major institutional holder is RUBRIC CAPITAL MANAGEMENT LP, with the holding of over 3.52 million shares as of 2024-06-30. The firm’s total holdings are worth over $15.33 million and represent 9.042% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Dec 31, 2024 , the former fund manager holds about 2.26% shares in the company for having 1.14 shares of worth $2.65 million while later fund manager owns 854.33 shares of worth $1.99 million as of Feb 28, 2025 , which makes it owner of about 1.70% of company’s outstanding stock.
